Sagimet Biosciences Inc.

SGMT | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.25

+$0.45 (+4.17%)

Sep 22, 2026, 11:27 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-51.04M	-45.57M	-27.88M	-30.5M	-24.44M	-11.37M
Depreciation & Amortization	n/a	n/a	n/a	130K	n/a	n/a
Stock-Based Compensation	6.45M	5.29M	4.99M	1.88M	1.9M	775K
Other Working Capital	-1.98M	-141K	-1.1M	4.21M	-55K	75K
Other Non-Cash Items	-8K	-1.11M	98K	-215K	883K	104K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.05M	-1.05M	-978K	4.21M	-55K	75K
Operating Cash Flow	-45.65M	-42.44M	-23.77M	-24.49M	-21.71M	-10.42M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-106.86M	-108.09M	-19.62M	-41.45M	n/a	n/a
Sales Maturities Of Investments	111.42M	46.4M	32.2M	9.44M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	20K
Investing Cash Flow	4.56M	-61.68M	12.58M	-32.01M	n/a	20K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-931K	-3.51M	-85K	-1.07M	n/a
Financial Cash Flow	275K	104.82M	86.17M	-73K	9.74M	68.89M
Net Cash Flow	-40.82M	701K	74.98M	-56.57M	-11.97M	58.49M
Free Cash Flow	-45.65M	-42.44M	-23.77M	-24.49M	-21.71M	-10.42M
Adj. Free Cash Flow	-52.1M	-47.72M	-28.76M	-26.37M	-23.61M	-11.19M
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-45.65M	-42.44M	-23.77M	-24.49M	-21.71M	-10.42M